Asia-Pacific PCR Multiplex Assays Market – Industry Trends & Forecast to 2026
Short Description
By Products & Services (Reagents & Consumables, Instruments & Accessories, Software and Services), Applications (Clinical Diagnostics, Research & Development), End User (Hospitals, Clinical Laboratories, Pharmaceutical & Biotechnology Companies, Research Institutes, Others), Country (China, Japan, India, Australia, Singapore, Indonesia, Thailand, South Korea, Malaysia, Philippines and Rest of Asia-Pacific)
Market Definition:
The multiplex assays can be applied for detection of pathogens and causing agents of infectious diseases such as viruses, bacteria and parasites. With the wide application of the PCR multiplex assays in drug discovery, bio marker discovery, clinical research and diagnostic of infectious diseases and genetic disorders in research and development laboratories, leading the manufacturers to advances the multiplex assays by overcoming the challenges of the optimization of PCR multiplexes. The PCR multiplex can be distinguished in single template PCR reaction and multiple template PCR reaction.
The automated PCR system is designed with the advanced technology which can detect multiple targets in single test. Quanterix (U.S.) offers Quanterix SR-Plex benchtop instrument which is designed with automated HD-1 Analyzer which helps in the detection of measurement of biomarkers with extraordinary sensitivity. The instrument utilizes single molecule measurements to evaluate previously undetectable proteins and reduces sample volume.
The simultaneously amplification of the multiple sequences in a single reaction is a cost effective, adequate, rapid and accurate procedure of clinical research laboratories. For the multiplex reaction with PCR primer, is required for successful reaction of multiplex. The PCR multiplex assays are designed for high throughput SNP genotyping, pathogen identification, mutation analysis, gene deletion analysis, linkage analysis, template quantitation, RNA detection and other forensic studies.
Market Segmentation:
Asia-Pacific PCR multiplex assays market is segmented into three notable segments which are products & services, application and end user.
• On the basis of products & services, the market is segmented into reagents & consumables, instruments & accessories and software and services.
• On the basis of application, the market is segmented into research & development and clinical diagnostics.
• On the basis of end user, the market is segmented into pharmaceutical & biotechnology companies, research institutes, hospitals, clinical laboratories and others.
Market Players
The key market players are listed below
• Thermo Fisher Scientific Inc.
• Luminex Corporation
• BD
• QIAGEN
• Agilent Technologies Inc.
• Meso Scale Diagnostics, LLC
• Randox Laboratories Ltd.
• Bio-Techne, Seegene Inc.
• Olink
• Illumina, Inc.
• Bio-Rad Laboratories, Inc.
• Abcam Plc
• Quanterix
• Sysmex Corporation
• Siemens
• F. Hoffmann-La Roche Ltd
• Hologic Inc.
• Diasorin
• Abbott
• Quest Diagnostics Incorporated
• PerkinElmer Inc.
• Eurofins Scientific
• Agena Bioscience, Inc.
The single user license is non-downloadable and non-printable. Global Site license allows these actions.
- 1 Introduction
- 1.1 Objectives Of The Study
- 1.2 Market Definition
- 1.3 Overview Of Asia-pacific Pcr Multiplex Assays Market
- 1.4 Currency And Pricing
- 1.5 Limitations
- 1.6 Markets Covered
- 2 Market Segmentation
- 2.1 Markets Covered
- 2.2 Asia-pacific Pcr Multiplex Assays Market: Geographical Scope
- 2.3 Years Considered For The Study
- 2.4 Currency And Pricing
- 2.5 Dbmr Tripod Data Validation Model
- 2.6 Primary Interviews With Key Opinion Leaders
- 2.7 Dbmr Market Position Grid
- 2.8 Market Application Coverage Grid
- 2.9 Dbmr Vendor Share Analysis
- 2.10 Multivariate Modeling
- 2.11 Products Lifeline Curve
- 2.12 Secondary Sources
- 2.13 Assumptions
- 3 Market Overview
- 3.1 Drivers
- 3.1.1 Technological Advancements Of Pcr Multiplex Assays
- 3.1.2 Introduction Of Novel Automated Systems
- 3.1.3 Growing Research And Development For Drug Discovery
- 3.1.4 Use Of Multiplex Assays In Companion Diagnostics
- 3.2 Restraints
- 3.2.1 High Cost Of The Multiplex Assays
- 3.2.2 Stringent Regulations And Standards
- 3.3 Opportunities
- 3.3.1 Growing Validation Of Biomarkers In Molecular And Protein Diagnostics
- 3.3.2 Business Expansion For Development Of Pcr Multiplex Assays
- 3.4 Challenge
- 3.4.1 Lack Of Proficient Labour To Handle Advanced Procedures
- 4 Executive Summary
- 5 Premium Insights
- 6 Asia-pacific Pcr Multiplex Assays Market, By Products & Services
- 6.1 Overview
- 6.2 Reagents & Consumables
- 6.3 Instruments & Accessories
- 6.4 Software And Services
- 7 Asia-pacific Pcr Multiplex Assays Market, By Application
- 7.1 Overview
- 7.2 Clinical Diagnostics
- 7.2.1 Cancer
- 7.2.2 Cardiovascular Diseases
- 7.2.3 Respiratory Diseases
- 7.2.4 Metabolism & Endocrinology Disorders
- 7.2.5 Nervous System Disorders
- 7.2.6 Autoimmune Diseases
- 7.2.7 Allergies
- 7.2.8 Others
- 7.3 Research & Development
- 7.3.1 Drug Discovery & Development
- 7.3.2 Biomarker Discovery & Validation
- 8 Asia-pacific Pcr Multiplex Assays Market, By End User
- 8.1 Overview
- 8.2 Hospitals
- 8.3 Clinical Laboratories
- 8.4 Pharmaceutical & Biotechnology Companies
- 8.5 Research Institutes
- 8.6 Others
- 9 Asia-pacific Pcr Multiplex Assays Market, By Geography
- 9.1 Asia-pacific
- 9.1.1 China
- 9.1.2 Japan
- 9.1.3 India
- 9.1.4 Australia
- 9.1.5 South Korea
- 9.1.6 Singapore
- 9.1.7 Malaysia
- 9.1.8 Indonesia
- 9.1.9 Thailand
- 9.1.10 Philippines
- 9.1.11 Rest Of Asia-pacific
- 10 Asia-pacific Pcr Multiplex Assays Market, Company Landscape
- 10.1 Company Share Analysis: Asia-pacific
- 11 Swot Analysis
- 11.1 Strength: - Significant Increasing Shares In Market Focused Segment
- 11.2 Strength: - Strong Asia-pacific Presence And Market Share
- 11.3 Weakness: - Product Recall
- 11.4 Opportunity: - Strategic Investments
- 11.5 Threat: - Stiff Competition
- 12 Company Profiles
- 12.1 F. Hoffmann-la Roche Ltd.
- 12.1.1 Company Snapshot
- 12.1.2 Revenue Analysis
- 12.1.3 Company Share Analysis
- 12.1.4 Product Portfolio
- 12.1.5 Recent Developments
- 12.2 Hol0gic Inc
- 12.2.1 Company Snapshot
- 12.2.2 Revenue Analysis
- 12.2.3 Company Share Analysis
- 12.2.4 Product Portfolio
- 12.2.5 Recent Developments
- 12.3 Luminex Corporation.
- 12.3.1 Company Snapshot
- 12.3.2 Revenue Analysis
- 12.3.3 Company Share Analysis
- 12.3.4 Product Portfolio
- 12.3.5 Recent Developments
- 12.4 Becton, Dickinson And Company
- 12.4.1 Company Snapshot
- 12.4.2 Revenue Analysis
- 12.4.3 Company Share Analysis
- 12.4.4 Product Portfolio
- 12.4.5 Recent Developments
- 12.5 Abbott
- 12.5.1 Company Snapshot
- 12.5.2 Revenue Analysis
- 12.5.3 Product Portfolio
- 12.5.4 Recent Developments
- 12.6 Agena Bioscience, Inc
- 12.6.1 Company Snapshot
- 12.6.2 Product Portfolio
- 12.6.3 Recent Development
- 12.7 Agilent Technologies, Inc
- 12.7.1 Company Snapshot
- 12.7.2 Revenue Analysis
- 12.7.3 Product Portfolio
- 12.7.4 Recent Development
- 12.8 Bio-rad Laboratories, Inc.
- 12.8.1 Company Snapshot
- 12.8.2 Revenue Analysis
- 12.8.3 Product Portfolio
- 12.8.4 Recent Developments
- 12.9 Biomérieux Sa
- 12.9.1 Company Snapshot
- 12.9.2 Revenue Analysis
- 12.9.3 Product Portfolio
- 12.9.4 Recent Developments
- 12.10 Biotek Instruments, Inc.
- 12.10.1 Company Snapshot
- 12.10.2 Product Portfolio
- 12.10.3 Recent Development
- 12.11 Diasorin S.P.A
- 12.11.1 Company Snapshot
- 12.11.2 Revenue Analysis
- 12.11.3 Product Portfolio
- 12.11.4 Recent Development
- 12.12 Eurofins Scientific
- 12.12.1 Company Snapshot
- 12.12.2 Revenue Analysis
- 12.12.3 Product Portfolio
- 12.12.4 Recent Development
- 12.13 Illumina, Inc.
- 12.13.1 Company Snapshot
- 12.13.2 Revenue Analysis
- 12.13.3 Product Portfolio
- 12.13.4 Recent Development
- 12.14 Olink
- 12.14.1 Company Snapshot
- 12.14.2 Product Portfolio
- 12.14.3 Recent Development
- 12.15 Pathonostics B.V.
- 12.15.1 Company Snapshot
- 12.15.2 Product Portfolio
- 12.15.3 Recent Development
- 12.16 Perkinelmer Inc.
- 12.16.1 Company Snapshot
- 12.16.2 Revenue Analysis
- 12.16.3 Product Portfolio
- 12.16.4 Recent Development
- 12.17 Qiagen
- 12.17.1 Company Snapshot
- 12.17.2 Revenue Analysis
- 12.17.3 Product Portfolio
- 12.17.4 Recent Developments
- 12.18 Quest Diagnostics Incorporated
- 12.18.1 Company Snapshot
- 12.18.2 Revenue Analysis
- 12.18.3 Product Portfolio
- 12.18.4 Recent Development
- 12.19 Randox Laboratories Ltd.
- 12.19.1 Company Snapshot
- 12.19.2 Product Portfolio
- 12.19.3 Recent Development
- 12.20 Seegene Inc.
- 12.20.1 Company Snapshot
- 12.20.2 Revenue Analysis
- 12.20.3 Product Portfolio
- 12.20.4 Recent Development
- 12.21 Siemens
- 12.21.1 Company Snapshot
- 12.21.2 Revenue Analysis
- 12.21.3 Product Portfolio
- 12.21.4 Recent Developments
- 12.22 Sysmex Corporation
- 12.22.1 Company Snapshot
- 12.22.2 Revenue Analysis
- 12.22.3 Product Portfolio
- 12.22.4 Recent Developments
- 12.23 Thermo Fisher Scientific Inc.
- 12.23.1 Company Snapshot
- 12.23.2 Revenue Analysis
- 12.23.3 Product Portfolio
- 12.23.4 Recent Development
- 13 Conclusion
- 14 Questionnaire
- 15 Related Reports
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook